Literature DB >> 1445878

Identification of the ubiquinone-binding site of NADH:ubiquinone oxidoreductase (complex I) from Neurospora crassa.

H Heinrich1, S Werner.   

Abstract

In order to localize the ubiquinone-binding site of complex I (NADH:ubiquinone oxidoreductase), a novel photoreactive ubiquinone analogue (Q0C7ArN3) has been synthesized. It is shown that the direct chemical precursor of this analogue (Q0C7ArNO2) and the analogue itself are accepted as substrates in an enzyme assay utilizing ubiquinone-depleted mitochondrial membranes of Neurospora crassa. The activity of the enzyme applying these derivatives is inhibited by 50% at a concentration of 9 and 20 microM rotenone. Photoaffinity labeling experiments were performed with both isolated complex I and whole mitochondrial membranes of N. crassa under various conditions. In each of these experiments a protein subunit with an apparent molecular mass of about 9.5 kDa was labeled with high specificity. Radioactive labeling was totally prevented by the addition of ubiquinone-2 at concentrations higher than 500 microM but was not affected by comparable concentrations of rotenone or other hydrophobic substances. In the labeling experiments using whole membranes, the labeling signal was dramatically increased in the presence of 1.5 mM NADH. These results strongly suggest that the ubiquinone analogue interacts specifically with the enzyme.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1445878     DOI: 10.1021/bi00161a020

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Use of transmitochondrial cybrids to assign a complex I defect to the mitochondrial DNA-encoded NADH dehydrogenase subunit 6 gene mutation at nucleotide pair 14459 that causes Leber hereditary optic neuropathy and dystonia.

Authors:  A S Jun; I A Trounce; M D Brown; J M Shoffner; D C Wallace
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

2.  Synthesis and characterization of new piperazine-type inhibitors for mitochondrial NADH-ubiquinone oxidoreductase (complex I).

Authors:  Naoya Ichimaru; Masatoshi Murai; Nobuyuki Kakutani; Junko Kako; Atsushi Ishihara; Yoshiaki Nakagawa; Takaaki Nishioka; Takao Yagi; Hideto Miyoshi
Journal:  Biochemistry       Date:  2008-09-10       Impact factor: 3.162

Review 3.  Characteristics of the energy-transducing NADH-quinone oxidoreductase of Paracoccus denitrificans as revealed by biochemical, biophysical, and molecular biological approaches.

Authors:  T Yagi; T Yano; A Matsuno-Yagi
Journal:  J Bioenerg Biomembr       Date:  1993-08       Impact factor: 2.945

4.  The specificity of mitochondrial complex I for ubiquinones.

Authors:  M Degli Esposti; A Ngo; G L McMullen; A Ghelli; F Sparla; B Benelli; M Ratta; A W Linnane
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

Review 5.  Biochemistry of aerobic biological methane oxidation.

Authors:  Christopher W Koo; Amy C Rosenzweig
Journal:  Chem Soc Rev       Date:  2021-01-25       Impact factor: 54.564

6.  Inhibitory Effects of Amorphigenin on the Mitochondrial Complex I of Culex pipiens pallens Coquillett (Diptera: Culicidae).

Authors:  Mingshan Ji; Yaping Liang; Zumin Gu; Xiuwei Li
Journal:  Int J Mol Sci       Date:  2015-08-20       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.